Skip to main content
Clinical Trials/NCT05187364
NCT05187364
Completed
Not Applicable

BioWare to Enhance Treatment for Alcohol Use Disorder and Posttraumatic Stress Disorder

Medical University of South Carolina1 site in 1 country4 target enrollmentMay 5, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
PTSD
Sponsor
Medical University of South Carolina
Enrollment
4
Locations
1
Primary Endpoint
Percentage of Participants Who Turn on and Off Equipment in 5 Minutes or Less
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

This study examines the ability of an innovative telehealth technology system to enhance Concurrent Treatment of PTSD and Substance Use Disorders using Prolonged Exposure (COPE) talk-therapy for individuals with posttraumatic stress disorder (PTSD) and alcohol use disorder.

Registry
clinicaltrials.gov
Start Date
May 5, 2022
End Date
February 20, 2023
Last Updated
3 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Amber Jarnecke

Research Assistant Professor

Medical University of South Carolina

Eligibility Criteria

Inclusion Criteria

  • Male or female; aged 18-70 years.
  • Able to provide written informed consent.
  • Meet DSM-5 diagnostic criteria for current moderate to severe alcohol use disorder.
  • Meet DSM-5 diagnostic criteria for current PTSD.
  • Participants taking psychotropic medications will be required to be maintained on a stable dose for at least 4 weeks before study initiation.

Exclusion Criteria

  • Meet DSM-5 criteria for a history of or current psychotic or bipolar disorders.
  • Current suicidal or homicidal ideation and intent.
  • Psychotropic medications which have been initiated during the past 4 weeks.
  • Acute alcohol withdrawal.
  • Pregnancy or breastfeeding for people of childbearing potential.
  • Currently enrolled in evidence based behavioral treatment for AUD or PTSD.
  • Implanted electronic devices of any kind, including pacemakers, electronic infusion pumps, stimulators, defibrillators or similar.

Outcomes

Primary Outcomes

Percentage of Participants Who Turn on and Off Equipment in 5 Minutes or Less

Time Frame: In-Session Visit (approximately 1 week from baseline)

Feasibility is 80% of participants turning on and off equipment in 5 minutes or less

System Usability Scale

Time Frame: Week 12

The System Usability Scale measures how usable and acceptable a product is. This scale ranges from 0-100 with higher scores being indicative of greater usability/acceptability. A mean score of 68 or greater is considered acceptable.

Study Sites (1)

Loading locations...

Similar Trials